Preclinical toxicological study of prolonged exposure to ketamine as an antidepressant (2020)
Source: Pharmacological Reports. Unidade: FMVZ
Subjects: ANÁLISE TOXICOLÓGICA, ANTIDEPRESSIVOS, BIOQUÍMICA, NEUROQUÍMICA
ABNT
ZACCARELLI‐MAGALHÃES, Julia et al. Preclinical toxicological study of prolonged exposure to ketamine as an antidepressant. Pharmacological Reports, v. 72, p. 24-35, 2020Tradução . . Disponível em: https://doi.org/10.1007/s43440-019-00014-z. Acesso em: 15 nov. 2024.APA
Zaccarelli‐Magalhães, J., Fukushima, A. R., Moreira, N., Manes, M., Abreu, G. R. de, Ricci, E. L., et al. (2020). Preclinical toxicological study of prolonged exposure to ketamine as an antidepressant. Pharmacological Reports, 72, 24-35. doi:10.1007/s43440-019-00014-zNLM
Zaccarelli‐Magalhães J, Fukushima AR, Moreira N, Manes M, Abreu GR de, Ricci EL, Waziry PAF, Spinosa H de S. Preclinical toxicological study of prolonged exposure to ketamine as an antidepressant [Internet]. Pharmacological Reports. 2020 ; 72 24-35.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s43440-019-00014-zVancouver
Zaccarelli‐Magalhães J, Fukushima AR, Moreira N, Manes M, Abreu GR de, Ricci EL, Waziry PAF, Spinosa H de S. Preclinical toxicological study of prolonged exposure to ketamine as an antidepressant [Internet]. Pharmacological Reports. 2020 ; 72 24-35.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s43440-019-00014-z